Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
Read More
1 minute read

Chico’s FAS Penned A Deal To Be Acquired By Sycamore Partners For $1B; Chico’s FAS Shareholders To Receive $7.60 Per Share In Cash

By Benzinga Newsdesk
September 28, 7:58 AM
FORT MYERS, Fla., Sept. 28, 2023 /PRNewswire/ -- Chico's FAS, Inc. (NYSE: CHS) ("Company" or "Chico's FAS") today announced that it has entered into a definitive agreement to be acquired byFORT MYERS, Fla., Sept. 28, 2023 /PRNewswire/ -- Chico's FAS, Inc.

CHS

Read More
3 minute read

EXCLUSIVE: The SAFER Banking Act Is A Long-Awaited First Step Towards The Economic Legitimacy Of The Cannabis Industry, Says Benzinga Cannabis Capital Conference Panelist

By Joana Scopel
September 27, 7:40 PM
“We are thrilled that the Senate Banking Committee has approved the SAFE Banking Bill,” said Boris Jordan, founder and chairman of Curaleaf Holdings, Inc. (OTCQX: CURLF), reflecting the sentiments of cannabis industry stakeholders following the historic approval o

ACRHF

Read More
1 minute read

Cellectis To Present Pre-Clinical Data On Multi-Armored Allogeneic MUC1-CAR T-cells Targeting Triple-Negative Breast Cancer At The Society For Immunotherapy Of Cancer 38th Annual Meeting

By Benzinga Newsdesk
September 27, 4:42 PM
Cellectis (the "Company") (NASDAQ:CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, announced today that pre-clinical data on

CLLS